TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing

Conclusion: These results demonstrate that targeted sequencing can reliably identify mutations in individual tumors that make this technology a possibility for clinical use.

Source: Cancer Genomics and Proteomics - April 21, 2016 Category: Cancer & Oncology Authors: ZHENG, H., WANG, Y., TANG, C., JONES, L., YE, H., ZHANG, G., CAO, W., LI, J., LIU, L., LIU, Z., ZHANG, C., LOU, F., LIU, Z., LI, Y., SHI, Z., ZHANG, J., ZHANG, D., SUN, H., DONG, H., DONG, Z., GUO, B., YAN, H., LU, Q., HUANG, X., CHEN, S.-Y. Tags: Article Source Type: research